Week of June 27, 2016
- Mayne Pharma buys $652M slice of Teva and Allergan’s US generics portfolio
- Former Pfizer exec invests in $10M Series A for cancer startup
- Moderna Gets Upfront $200M Cash, Ties New Cancer Pact With Merck & Co.
- Novartis goes bispecific with Xencor in up to $2.6B immuno-oncology deal
- Medpace shoots for $150M IPO as CRO sector booms
Week of June 20, 2016
- Bay Area startup Annexon Biosciences banks $44M Series B
- Impax buys generic products from Teva and Allergan for $586M
- Celgene inks $50M in cancer collaborations with four research institutions
- UMass team nabs $17M from NIAID for HIV vaccine work
- Reflexion health raises $18M Series B game based orthopedic rehabilitation
Week of June 13, 2016
- Carbylan Therapeutics to merge with Kalvista Pharmaceuticals
- Perrigo stock spikes on rumors of mystery $20B acquisition bid
- Icon Pfizer ink services pact
- Bay Area startup Blade Therapeutics pulls in $45M in funding
- Sagent buys five ANDAS including Propofol from Teva for $40m
Week of June 6, 2016
- Merck bags PhIII-bound Afferent Pharma in $1.25B deal
- AstraZeneca gins up $520M-plus selling anesthetics rights to Aspen
- Valeant (VRX) Mulls Over Selling Egyptian Drugmaker Amoun and Latin American Assets
- M&A back on the table as ‘big pharma’ targets smaller rivals
Week of May 30, 2016
- Partners Group acquires PCI Pharma Services
- AstraZeneca PLC unloads Gout drug rights to Grunenthal
- Boehringer Ingelheim and Inventiva collaborate
- Jazz Pharmaceuticals agrees to buy Celator for about $1.5B
- Shire, Baxalta complete $32B merger
Week of May 23, 2016
- Colorcon to buy BASF’s Kollicoat coating system product
- Celgene and Gilead both possible new suitors to acquire Medivation
- Genentech, Evotec extend drug discovery alliance
- MorphoSys, MD Anderson partner to develop mAbs against cancer
- Biotech entrepreneurs raise $49M to bankroll a neuroscience startup
Week of May 16, 2016
- Alvotech acquires Baliopharm
- Pfizer to acquire Anacor Pharmaceuticals
- Agios, Celgene hammer out $1B+ Metabolic Immuno-Oncology Deal
- J&J commits $740M for its second cancer R&D pact with Macrogenics
- Bavarian Nordic wins $100M bulk supply order from Barda for Imvamune
Week of May 9, 2016
- Cell Therapy offloads Japanese rights to heart regen medicine to Daiichi
- Californian biotechs sign neoantigen cancer vaccine pact
- Medivation opens books to Pfizer, Amgen as bidders circle
- Bayer Rumored to be Exploring Bid for $40 Billion Seed Company Monsanto
- Ferrer to Acquire Alexza Pharmaceuticals
Week of May 2, 2016
- Quintiles, IMS Health announce merger
- China’s CSPC inks $106M deal with Allergan unit
- Pfizer turns to WaVe Life Sciences for drug discovery in deal worth $911M
- Ergomed inks Haemostatix deal to gain surgical bleeding control assets
- Amri to acquire Euticals for $358m
Week of April 18, 2016
- Heptares, Kymab to develop novel antibody therapeutics
- Abbvie, University of Chicago launch cancer research alliance
- GSK – Sanford Burnham Prebys Medical Discovery Institute launch Neuroscience Lab in SoCal
- Bioclinica, ArisGlobal partner on pharmacovigilance services
- Halo Pharma and Exxpharma to collaborate
Week of April 11, 2016
- Sanofi, Dice Molecules launch research collaboration
- Kala Pharma closes $68M series C Funding
- Juno and WuXi AppTec announce new cell therapy company
- Forbion raises $200m for EU and North American biotech
Week of April 2, 2016
- Medidata acquires medical imaging company
- Tesaro inks $450M Prostate Cancer Deal with Janssen (J&J)
- Lumos Pharma secures $34M in Series B financing
- Humanwell Healthcare,PuraCap acquire Epic Pharma
- FTSE lifted by pharma companies as Pfizer deal falls apart
- FIT Biotech, Ichor launches Infectious Disease Collaboration
Week of March 28, 2016
- Partnering deal flow continues its torrid pace to start year
- Amgen is eyeing heftier deals, but so are its biggest rivals
- J&J signs deal with Chinese company for hepatitis B drug
- Blueprint inks Roche deal with more than $1b in potential payments
- Affymetrix spurns bid by former execs in favor of $1.3B offer from Thermo Fisher
- Teva’s $40.5 billion generics deal with Allergan hits FTC snag
- NZ diagnostic company Pictor scores major licensing deal for low-cost blood test
Week of March 21, 2016
- Janssen R&D forges Clinical Trials agreement with Genentech
- R-Biopharm, Merck KGaA aunch Companion Diagnostics collaboration
- Bristol Myers Squibb acquires Padlock Therapeutics in $600M deal
- LakePharma acquires Blue Sky Bioservices
- RTP’s Envisia raises $16.5M to develop drugs to improve vision
Week of March 14, 2016
- Dr Reddys- Tr Pharm in Biosimilars Alliance
- Gyros, Protein Technologies announce merger
- Blueprint Medicines announces worldwide collaboration with Roche to develop cancer immunotherapy
- ImmunogenX acquires the Assets Alvine Pharmaceuticals
- Bay Area startup DiCE Molecules inks $2.3B deal with Sanofi
- Vectura purchases rival Skyepharma for $620
Week of March 7, 2016
- Synexus buys US trial site network for patient access following recent deals by Icon, PRA and PPD
- Almac Opens Additional Companion Diagnostic Lab in NC
- Abbvie, Boehringer Ingelheim launch $595M collaboration to develop Phase III Psoriasis candidate
- With Agreements for $60M, Argos can get to end of Phase 3 clinical trial
- Sanofi, Merk split long standing vaccine joint venture In Europe
- Crown Bioscience acquires PreClinOmics